NOVATO, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today announced that clinical, preclinical and manufacturing data from its investigational gene therapy programs will be presented at the American... Learn More
-PNI will use the investment to advance a cost-effective Made-in-Canada COVID-19 vaccine -PNI offers expertise in self-amplifying mRNA vectors, lipid-based drug delivery systems and nanomedicine manufacturing -PNI will contribute to Canada’s ability to secure an effective COVID-19 vaccine and build technologies towards enabling rapid... Learn More
Investment will bring Canada’s first centre of manufacturing excellence of nanomedicine-based RNA vaccines, gene therapies and cell therapies. -At project completion early in 2023, the approximately 40,000 square foot leased bio-manufacturing facility will have multiple GMP suites with manufacturing lines for the end-to-end manufacturing of genetic medicines.... Learn More
Vancouver, BC, Apr 20, 2021 - Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, today launched the GenVoy-ILM™ T Cell Kit for mRNA to enable lipid nanoparticle (LNP)-based ex vivo gene transfer. Scientists can now use mRNA-LNP to efficiently and reproducibly generate high yields of... Learn More
IsoPlexis today announced that it has been named by Fierce Medtech as one of 2020's Fierce 15, designating it as one of the most promising private companies in the industry. IsoPlexis, the leader in functional single-cell proteomics, provides crucial tools to researchers, enabling them to access new layers... Learn More
IsoPlexis today announced that its IsoSpark system has been named a winner in the 2021 BIG Innovation Awards presented by the Business Intelligence Group. The breakthrough IsoSpark platform is a critical tool that provides new and accessible layers of biological data at the single-cell level, and the ability to... Learn More